Which has the lower trailing P/E, DXCM or IDXX?

DXCM has the lower trailing P/E: DXCM trades at 33.47 and IDXX at 36.09. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, DXCM or IDXX?

Over the past five years, DXCM grew revenue faster — DXCM at a 18.03% CAGR versus IDXX at 8.37%.

Is DXCM or IDXX more profitable?

IDXX runs the higher net margin — DXCM at 20.12% versus IDXX at 25.03%.

How have DXCM and IDXX total returns compared?

Over the past 10 years, DXCM delivered 13.57% and IDXX delivered 16.45% annualized total return. Past performance doesn't predict future results.

DexCom, Inc. (DXCM) vs IDEXX Laboratories, Inc. (IDXX)

A side-by-side comparison of DexCom, Inc. and IDEXX Laboratories, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 13, 2026. Differences are shown without an overall score or investment verdict.

DXCM

DexCom, Inc.

$31.95B

$84.68HealthcareDelayed quote: Sep 14, 2026, 4:00 PM EDT

IDXX

IDEXX Laboratories, Inc.

$40.20B

$509.56HealthcareDelayed quote: Sep 14, 2026, 4:00 PM EDT

Total return — DXCM vs IDXX

growth of $100 · dividends reinvested · last 10y

DXCM +261.5% (+13.7%/yr)IDXX +342.9% (+16.0%/yr)IDXX compounded faster over this window

DXCM IDXX

DXCM vs IDXX: by the numbers

•IDXX is the larger company ($40.20B vs $31.95B market cap).
•DXCM trades at the lower trailing earnings multiple (33.47 vs 36.09 P/E), one valuation lens rather than an overall verdict.
•IDXX converts more revenue to profit (25.03% vs 20.12% net margin).
•DXCM grew revenue faster over the past five years (18.03% vs 8.37% CAGR).

Metrics side by side

Valuation

Metric	DXCM	IDXX
P/E ratio	33.47	36.09
Forward P/E	31.74	34.50
P/S ratio	6.43	8.83
P/B ratio	12.19	24.93
EV / EBITDA	22.98	25.48
FCF yield	4.40%	3.11%

Profitability

Metric	DXCM	IDXX
Gross margin	62.47%	62.45%
Operating margin	22.92%	32.03%
Net margin	20.12%	25.03%
ROE	38.14%	70.67%
ROIC	21.71%	41.33%

Growth (annualized)

Metric	DXCM	IDXX
Revenue CAGR (5Y)	18.03%	8.37%
EPS CAGR (5Y)	10.31%	14.07%
FCF CAGR (5Y)	69.49%	12.49%
Total return CAGR (5Y)	-9.57%	-5.83%

Frequently asked

Which has the lower trailing P/E, DXCM or IDXX?: DXCM has the lower trailing P/E: DXCM trades at 33.47 and IDXX at 36.09. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, DXCM or IDXX?: Over the past five years, DXCM grew revenue faster — DXCM at a 18.03% CAGR versus IDXX at 8.37%.
Is DXCM or IDXX more profitable?: IDXX runs the higher net margin — DXCM at 20.12% versus IDXX at 25.03%.
How have DXCM and IDXX total returns compared?: Over the past 10 years, DXCM delivered 13.57% and IDXX delivered 16.45% annualized total return. Past performance doesn't predict future results.

Go deeper

Full DXCM analysis Full IDXX analysis Interactive comparison tool

Dig into the metrics

DexCom P/E ratio IDEXX Laboratories P/E ratio DexCom ROE IDEXX Laboratories ROE DexCom operating margin IDEXX Laboratories operating margin DexCom revenue growth IDEXX Laboratories revenue growth DexCom free cash flow IDEXX Laboratories free cash flow

DexCom & IDEXX Laboratories appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks Highest Operating Margin Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 13, 2026.